Value profile for respiratory syncytial virus vaccines and monoclonal antibodies-Reference-Cited by-同舟云学术

Value profile for respiratory syncytial virus vaccines and monoclonal antibodies

Published:2023-11 Issue: Volume:41 Page:S7-S40
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Fleming Jessica A.,Baral Ranju,Higgins Deborah,Khan Sadaf,Kochar Sonali,Li You,Ortiz Justin R.,Cherian Thomas,Feikin Daniel,Jit Mark,Karron Ruth A.,Limaye Rupali J.,Marshall Caroline,Munywoki Patrick K.,Nair Harish,Newhouse Lauren C.,Nyawanda Bryan O.,Pecenka Clint,Regan Katie,Srikantiah Padmini,Wittenauer Rachel,Zar Heather J.,Sparrow Erin

Funder

World Health Organization

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference161 articles.

1. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study;Group PERCH;Lancet,2019

2. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

3. Assessing the full burden of respiratory syncytial virus in young infants in low- and middle-income countries: the importance of community mortality studies;Srikantiah;Clin Infect Dis,2021

4. Mortality from respiratory syncytial virus in children under 2 years of age: a prospective community cohort study in rural Maharashtra, India;Simões;Clin Infect Dis,2021

5. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease;Sikkel;Pediatr Infect Dis J,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024);Vaccines;2024-06-08

2. Healthcare Providers’ and Pregnant People’s Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus;Vaccines;2024-05-20

3. Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2024-05-05

4. An amplicon-based protocol for whole-genome sequencing of human respiratory syncytial virus subgroup A;Biology Methods and Protocols;2024-01-01

5. Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022;Vaccine;2023-11